We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$816B
AUM Growth
+$71.6B
Cap. Flow
-$12.2B
Cap. Flow %
-1.5%
Top 10 Hldgs %
32.14%
Holding
3,021
New
108
Increased
1,941
Reduced
738
Closed
64

Top Buys

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$2.03B
2
ROK icon
Rockwell Automation
ROK
+$1.44B
3
ADSK icon
Autodesk
ADSK
+$1.15B
4
C icon
Citigroup
C
+$975M
5
COP icon
ConocoPhillips
COP
+$967M

Sector Composition

Rank Sector Weight
1 Technology 32.21%
2 Healthcare 15.42%
3 Financials 10.99%
4 Consumer Discretionary 10.39%
5 Communication Services 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLL
2501
DELISTED
Piedmont Lithium
PLL
$254K ﹤0.01%
19,054
+6,328
+50% +$102K
EAF icon
2502
GrafTech
EAF
$203M
$253K ﹤0.01%
18,290
+822
+5% +$12.8K
LXRX icon
2503
Lexicon Pharmaceuticals
LXRX
$1.04B
$253K ﹤0.01%
105,315
+4,624
+5% +$9.93K
EB
2504
DELISTED
Eventbrite
EB
$252K ﹤0.01%
45,911
-13,763
-23% -$99.8K
FA icon
2505
First Advantage
FA
$3.81B
$252K ﹤0.01%
15,478
+2,163
+16% +$35.3K
OLP
2506
One Liberty Properties
OLP
$537M
$251K ﹤0.01%
11,077
+580
+6% +$12.3K
RDUS
2507
DELISTED
Radius Recycling
RDUS
$251K ﹤0.01%
11,864
+1,099
+10% +$25.9K
UEIC icon
2508
Universal Electronics
UEIC
$66.6M
$251K ﹤0.01%
25,000
CRSR icon
2509
Corsair Gaming
CRSR
$1.45B
$250K ﹤0.01%
20,235
+1,348
+7% +$17.5K
SIGA icon
2510
SIGA Technologies
SIGA
$207M
$250K ﹤0.01%
29,180
+2,218
+8% +$12.7K
VGK icon
2511
Vanguard FTSE Europe ETF
VGK
$31.1B
$250K ﹤0.01%
+3,707
New +$240K
NPKI
2512
NPK International
NPKI
$1.18B
$250K ﹤0.01%
34,521
+3,232
+10% +$21.1K
STRS
2513
DELISTED
STRATUS PPTYS INC
STRS
$248K ﹤0.01%
10,862
+525
+5% +$12.3K
SPWR
2514
DELISTED
SunPower Corporation Common Stock
SPWR
$248K ﹤0.01%
82,583
+19,501
+31% +$64.2K
FNKO icon
2515
Funko
FNKO
$335M
$246K ﹤0.01%
39,335
+2,689
+7% +$18.9K
GNK icon
2516
Genco Shipping & Trading
GNK
$1.13B
$246K ﹤0.01%
12,058
+1,782
+17% +$33K
AMC icon
2517
AMC Entertainment Holdings
AMC
$2.35B
$245K ﹤0.01%
65,620
+12,975
+25% +$57.8K
OSBC icon
2518
Old Second Bancorp
OSBC
$1.31B
$245K ﹤0.01%
17,632
+1,807
+11% +$25.3K
TTEC icon
2519
TTEC Holdings
TTEC
$77.4M
$245K ﹤0.01%
23,619
+7,488
+46% +$125K
HCI icon
2520
HCI Group
HCI
$2.32B
$242K ﹤0.01%
+2,078
New +$204K
DCPH
2521
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$242K ﹤0.01%
15,355
+1,984
+15% +$30.5K
DCH
2522
Dauch Corp
DCH
$1.6B
$241K ﹤0.01%
32,725
+3,862
+13% +$29.1K
VZIO
2523
DELISTED
VIZIO Holding Corp.
VZIO
$241K ﹤0.01%
21,953
+2,983
+16% +$27.3K
AXGN icon
2524
Axogen
AXGN
$2.58B
$240K ﹤0.01%
29,650
+2,204
+8% +$19.7K
PGEN icon
2525
Precigen
PGEN
$2.32B
$240K ﹤0.01%
165,152
+5,304
+3% +$7.62K

Similar funds

T. Rowe Price Associates's Q1 2024 Portfolio in Review

As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
  • T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
  • T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
  • T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
  • T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.